These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 1245245)

  • 1. Sequential use of clomiphene citrate and human menopausal gonadotropin in ovulation induction.
    Kistner RW
    Fertil Steril; 1976 Jan; 27(1):72-82. PubMed ID: 1245245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of ovulation induction.
    Wu CH
    Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma estrogen monitoring of ovulation induction.
    Wu CH
    Obstet Gynecol; 1975 Sep; 46(3):294-8. PubMed ID: 1172219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
    Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
    Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
    Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction with gonadotropins in women with polycystic ovary disease.
    Kupferminc MJ; Lessing JB; Peyser MR
    J Reprod Med; 1991 Jan; 36(1):61-4. PubMed ID: 1901089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
    Wang CF; Gemzell C
    Fertil Steril; 1980 May; 33(5):479-86. PubMed ID: 6768596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
    Messinis IE; Templeton A; Baird DT
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic low-dose follicle-stimulating hormone compared with clomiphene/human menopausal gonadotropin for induction of ovulation.
    Yong EL; Ng SC; Chan CL; Kumar J; Teo LS; Ratnam SS
    Gynecol Endocrinol; 1997 Feb; 11(1):35-42. PubMed ID: 9086338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD; Tagatz GE; Steffes MW
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro fertilisation. A review of drug therapy and clinical management.
    Jennings JC; Moreland K; Peterson CM
    Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation.
    Lee KL; Couchman GM; Walmer DK
    J Assist Reprod Genet; 2005 Jan; 22(1):37-40. PubMed ID: 15807221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the combination of clomiphene citrate-human menopausal gonadotropin-human chorionic gonadotropin in the management of anovulation.
    Jarrell J; McInnes R; Cooke R; Arronet G
    Fertil Steril; 1981 Jun; 35(6):634-7. PubMed ID: 6788606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulation.
    Tal J; Paz B; Samberg I; Lazarov N; Sharf M
    Fertil Steril; 1985 Sep; 44(3):342-9. PubMed ID: 3928406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women.
    Abdelazim IA; Makhlouf HH
    Arch Gynecol Obstet; 2013 Mar; 287(3):591-7. PubMed ID: 23080548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal dysfunction in ovulation induction: the role of repetitive human chorionic gonadotropin supplementation during the luteal phase.
    Blumenfeld Z; Nahhas F
    Fertil Steril; 1988 Sep; 50(3):403-7. PubMed ID: 3137096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.